Psyence Biomedical Ltd
NASDAQ:PBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Psyence Biomedical Ltd
NASDAQ:PBM
|
CA |
|
FIRST BANK (Hamilton)
NASDAQ:FRBA
|
US |
|
C
|
China New Energy Ltd
HKEX:1156
|
CN |
|
1St Capital Bancorp
OTC:FISB
|
US |
|
MTY Food Group Inc
TSX:MTY
|
CA |
|
National Standard (India) Ltd
BSE:504882
|
IN |
|
MPS Infotecnics Ltd
NSE:VISESHINFO
|
IN |
Psyence Biomedical Ltd
Psyence Biomedical Ltd is a CA-based company operating in industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. Psyence Biomedical Ltd is a Canada-based company, which develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
Psyence Biomedical Ltd is a CA-based company operating in industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-12-10. Psyence Biomedical Ltd is a Canada-based company, which develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The firm has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
